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Abstract 
Background: Treatment of acute hypoxemic respiratory failure attempts to supply oxygen to the patient by 
non-invasive means initially (nasal cannula, non-rebreather, etc), when these treatments fail, it leads to 
patient sedation and intubation. There are established drawbacks of intubating patients and a focus has 
been placed on non-invasive ventilation delivery systems with the hope of decreasing intubation rates. 
The traditional facial mask has held ground as the standard of care, but newer applications including 
helmet delivered therapy hope to improve upon its foundation. 
Methods: An exhaustive literature search using MEDLINE-Ovid, CINAHL, and Web of Science with the 
search words helmet, NIV, intubation, respiratory distress, and respiratory insufficiency. Quality of 
evidence was evaluated using the GRADE. 
Results: Two studies were reviewed which analyzed patients suffering from acute respiratory failure and 
evaluating their need for intubation following application of either standard methods of mask NIV versus 
non-standard helmet NIV. After comparing the data between these studies there was a lower rate of 
intubation found when using helmet versus mask NIV in Antonelli et al (24% vs 32%). The second study of 
Chidini et al revealed similar rates of intubation when comparing helmet to mask (17% vs. 23%), but 
revealed a higher level of tolerance to the therapies. The overall quality of the studies was low and further 
studies should include a more narrow population focus. 
Conclusion: Helmet NIV is as effective or in some cases more effective than mask at delivering 
respiratory support to patients in acute respiratory distress, and does so more tolerably to the patient. 
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Abstract 
Background: Treatment of acute hypoxemic respiratory failure 
attempts to supply oxygen to the patient by non-invasive means 
initially (nasal cannula, non-rebreather, etc), when these treatments 
fail, it leads to patient sedation and intubation. There are established 
drawbacks of intubating patients and a focus has been placed on non-
invasive ventilation delivery systems with the hope of decreasing 
intubation rates. The traditional facial mask has held ground as the 
standard of care, but newer applications including helmet delivered 
therapy hope to improve upon its foundation.  
Methods:  An exhaustive literature search using MEDLINE-Ovid, 
CINAHL, and Web of Science with the search words helmet, NIV, 
intubation, respiratory distress, and respiratory insufficiency. Quality 
of evidence was evaluated using the GRADE. 
Results: Two studies were reviewed which analyzed patients suffering 
from acute respiratory failure and evaluating their need for intubation 
following application of either standard methods of mask NIV versus 
non-standard helmet NIV. After comparing the data between these 
studies there was a lower rate of intubation found when using helmet 
versus mask NIV in Antonelli et al (24% vs 32%). The second study of 
Chidini et al revealed similar rates of intubation when comparing 
helmet to mask (17% vs. 23%), but revealed a higher level of 
tolerance to the therapies. The overall quality of the studies was low 
and further studies should include a more narrow population focus. 
Conclusion:  Helmet NIV is as effective or in some cases more 
effective than mask at delivering respiratory support to patients in 
acute respiratory distress, and does so more tolerably to the patient. 
Keywords:  Intubation, respiratory insufficiency, respiratory distress, 
helmet, NIV 
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BACKGROUND 
In the setting of acute respiratory failure patients struggle to 
effectively bring air in or out of the lungs to perform gas exchange 
between CO2 and O2. The concern of this research is focused more on 
hypoxemic respiratory failure, the lack of oxygen being delivered to 
the blood stream. In serious cases, patients are traditionally given 
high flow O2 and monitored by their vital signs, if ineffective the airway 
is managed by endotracheal intubation. ET intubation is invasive, 
requires sedation of the patient, and can damage the airway 
mechanically and by introducing abnormal flora. The attempts to 
maximize non-invasive ventilation (NIV) are intended to hopefully 
avoid the drawbacks of ET intubation and lead to better outcomes. It 
has been shown to help patients achieve higher oxygen exchange 
rates in conditions of hypercapnic COPD exacerbations, 
cardiopulmonary edema, and acute hypoxemic respiratory failure 1,2 
The standard method of delivery has traditionally been applied 
via facial masks, which fit around the patient’s nose and mouth. 
However, with these traditional masks there are difficulties with 
fitment including leaking, aspiration concerns, and nasal or eye 
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irritations. The less tolerable a therapy is, the less compliance we see; 
with this in mind, a new delivery system which delivers CPAP through 
a helmet encompassing the entire head of the patient will be 
considered. This review evaluates studies that measure the efficacy of 
this new delivery system and look at the key parameters of success, 
namely toleration of the device and intubation rates.  
METHODS 
An exhaustive search of the literature was performed using 
MEDLINE-Ovid, CINAHL, and Web of Science. Keywords used included: 
helmet, NIV, intubation, respiratory distress, and respiratory 
insufficiency. Studies were required to include patient suffering from 
acute respiratory distress and evaluate the application of CPAP with 
helmet delivery and compare to standard of care, mask delivery. 
Articles were assessed for quality using the Grading of 
Recommendations, Assessment, Development, and Evaluation 
(GRADE).3
 
RESULTS 
 A total of 12 articles were found in the search strategy. After 
excluding duplicates and unrelated studies, 2 studies remained, 
including one randomized controlled trial5 and one pilot controlled 
study.4 The studies were compared for their efficacy in intubation rates 
and tolerability. See Table I. 
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Antonelli et al 
 This pilot study4 sought to assess the efficacy of noninvasive 
pressure support ventilation (NPSV) through use of a helmet as a first 
line approach to hypoxemic acute respiratory failure (ARF), as 
compared to the standard mask application. Patients must be without 
chronic obstructive pulmonary disease and with ARF (defined by 
severe dyspnea at rest, respiratory rate >30 breaths/min, PaO2:FIO2 < 
200, and active contractions of accessory muscles).4 
 Primary endpoints of the study were improvement of gas 
exchanges, need for intubation, and complications related to 
noninvasive ventilation (eg, skin necrosis, gastric distention, and 
intolerance). Gas exchange rates were evaluated at 1 hour and 4 hour 
marks or until mechanical ventilation was no longer used.4 
 Both groups showed similar improvement in PaO2:FIO2 within the 
first hour, 63% in the helmet treated group and 66% in the standard 
face mask treated group. PaCO2, pH, and respiratory rate were not 
different in the 2 groups over time. Eight patients (24%) of the helmet 
group and 21 patients (32%) in the facial mask group failed NPSV and 
required intubation. No patients failed NPSV because of intolerance in 
the helmet group; however, 8 patients (38%) in the mask group did.4 
See Table II. 
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Chidini et al 
This was a non-blinded, multicenter randomized controlled trial* 
comparing helmet and facial mask CPAP in infants with RSV-related 
ARF. It involved consecutive patients in 3 Italian PICUs (Fondazione 
IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Milan; University 
Hospital “A. Gemelli,” Catholic University of Sacred Heart, Rome; and 
Children’s Hospital Vittorw Buzzi, Istutui cLinici, di Perfezionamento, 
Milan)and followed from January 2008 to January 2010.5 
 The study consisted of 30 patients aged 6-12 months, 
concurrent RSV infection consistent with clinical features, and positive 
immunofluorescence test in nasopharyngeal swabs, and ARF. Patients 
were excluded if the patient needed emergency intubation, had a 
glascow coma scale <12, pH <7.25, cough or gag reflex impairment, 
upper airway obstruction, or facial or gastric surgery, experienced 
respiratory exhaustion, was hemodynamically unstable, or enrolled in 
another study. All patients received an amount of CPAP determined to 
obtain >94% (SpO2) with FIO2 <0.6 continuously for 24 hours.5 
 The primary endpoint was treatment failure, defined as: 
permanent discontinuation of the CPAP trial because of intolerance to 
the interface and/or need for intubation. Intolerance was assessed 
through the objective pain scale (OPS), see Appendix. Criteria for 
endotracheal intubation included failure to maintain Pao2>60mmHg 
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with Fio2<0.6, clinical signs of exhaustion, need to protect airways or 
manage copious secretions, and hemodynamic impairment.5 
 Treatment failure rate was higher with the mask (4/13, 30%) 
due to intolerance. Patients not tolerating the mask were successfully 
switched to the helmet. Intubation rates were the same in both groups 
~17-23%. Total application of CPAP was longer than with the helmet. 
Air leaks, skin sores, and need for sedation were all more frequent in 
the mask group.5 See Table III. 
DISCUSSION 
There are concerns with the tolerability of CPAP delivered via 
facemask, and it seems that the solution is use of a helmet. This 
review evaluates how helmet-delivered CPAP is effective by means of 
improved tolerability and reduced rates of intubation. The respective 
study of Antonelli et al4 demonstrated that the group receiving NPSV 
via helmet administration showed fewer rates of failure requiring 
intubation when compared to the mask application respectively 
(8/33=24% vs. 21/66=32%). Also, each therapy delivery method was 
effective at delivering the principle goal of improvement of Pa02:Fi02, 
showing initial improvement of 63% and 66%, for helmet and mask 
respectively. This demonstrates that each therapy method was equally 
effective at providing the desired goals of therapy, but that the helmet 
application was more tolerated with fewer negative outcomes.  
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At the same time Chidini et al5 recorded the rates of intubation 
as lower when using the helmet (3/17=17%) vs the mask 
(7/13=54%). There were significant increases for both applications in 
Pa02:Fi02 over time, along with decreases in respiratory rate and 
heart rate. Both studies4,5 reveal a more tolerable and equally effective 
method to deliver NPSV through helmet CPAP, less often requiring 
need for intubation. Again, clearly demonstrating that these therapies 
were both effectively accomplishing the goal of treatment, but the 
helmet doing so more effectively and with less interference.  
While these studies4,5 agree on similar endpoints, they had 
significant variance in the populations studied (both in age and disease 
state), level of blindness, and the sample sizes taken. The difference of 
age in the populations studied, demonstrates support for this therapy 
over a wide range of patients and conditions. The difference in age 
groups was a rather large disparity from 8-12months (Chidini et al5), 
versus 36-78years (Antonelli et al4). Clinically, these represent very 
different patients due to the physiology associated with their 
respective ages. Furthermore, the individuals aged less than a year 
and presenting in ARF, likely have very different etiology of disease 
rather than those afflicted with ARF in the older population.  
Younger patients tend to suffer from congenital defects, which 
manifest as poorly formed anatomical structures leading to inefficient 
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systems as compared to healthy young infants. On the other hand, an 
older population likely developed strong systems for respiration and 
circulation in infancy and proceeded to adulthood without limitation. 
The etiology of disease for an older population is likely secondary to 
environmental factors or degradation of previously healthy systems. 
While each population may have arrived in ARF from different causes, 
the objective application of the helmet CPAP proved to be equally as 
effective or better as the mask and in several regards more tolerable. 
This illustrates the effectiveness of the therapy over a spectrum of age 
and disease state.  
Secondly, there is an inherent difficulty in blinding participants 
and researchers by the physical presence of each respective device. In 
each study, it is not possible to hide from providers the placement of 
either the mask or helmet delivery system. Those interacting with the 
devices may have imposed a potential bias for either treatments’ 
success or failure. It is possible that due to the training of staff and 
preference to a specific device, better outcomes may be associated 
with the treatment the provider’s prefer. However, this bias did not 
seem play a large role in the acute setting of each patient’s care in the 
studies discussed, and the character of most staff members would 
provide optimal care, regardless of the device used to deliver it by.  
On the other hand, an argument can be made that better care 
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would have been delivered through a device more familiar to staff and 
altered the outcomes. The more standard of the 2 devices, the mask, 
has been the gold standard of treatment in ARF with CPAP for a length 
of time and one can assume provider’s would be more familiar with its 
use. If one device had an advantage in familiarity, the mask-fitted 
patients would reflect this. Therefore, this tendency would likely lead 
to an underestimate of the treatment effect.  In other words, the 
improved outcomes measured in those who were treated with the 
helmet are likely to be even greater if this risk bias was fully 
addressed. 
A final potential bias in each study was the limited number of 
participants, 30 in Chidini et al5 vs 99 in Antonelli et al4. A larger scale 
study would more clearly reveal the effectiveness of each therapy. 
Studies of smaller populations allow for unpredictable variables to 
represent a larger portion of the results, giving disproportionate weight 
to those variables in the findings. This would skew the data either 
more favorably or less favorably than a true representation of the 
population.  
CONCLUSION 
The studies collected and reviewed demonstrated similar 
effectiveness in the primary outcome of intubation rates. This alone 
would argue that either therapy can be selected as preferred by the 
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provider, facility, or cost of application device. However, both studies 
demonstrated a more favorable result towards helmet CPAP/NPV 
application with regards to tolerability of the device. Ultimately, a 
more tolerable therapy potentially leads to fewer intubation rates and 
allows a longer length of therapy, with fewer complications. The 
positive outcomes were achieved while maintaining baseline metrics of 
heart rate, respiratory rates, Sp02, and pH at similar responses. 
Clinically, the helmet delivery of CPAP/NPV should be applied as a first 
line treatment in the setting of ARF rather than mask application. If 
cost, training, or availability of device is a barrier to the transition from 
mask to helmet, a mask delivered CPAP/NPV treatment will remain 
adequate.   
The treatment of disease has been facilitated by the growing 
knowledge of physiology and pathology. As disease processes are 
understood in finer detail, treatments have been adjusted to be more 
safe, effective, and with less negative associations. The growth of 
knowledge alone only allows us to theorize how new methods of 
delivery could affect the outcomes. It is necessary to create and 
evaluate new interventions, to continually refine our medical approach 
and ultimately deliver the best care for the patient. This belies the 
nature of the helmet CPAP/NPV delivery, a new device created with the 
goal of better patient outcomes and ultimately delivering on that 
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ambition.   
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Tables 
Table I: Quality Assessment of Reviewed Articles 
Study 
Desig
n 
Downgrade Criteria Upgra
de 
Criteri
a 
Quality Limitatio
ns 
Indirectn
ess 
Inconsiste
ncy 
Imprecisi
on 
Publicati
on bias 
Anton
elli et 
al* 
Pilot 
trial 
Not 
seriousa 
Not 
Serious 
Not 
Serious 
Seriousb Unclearc None Modera
te 
Chidini 
et al* 
RCT Not 
Serious 
Not 
Serious 
Not 
Serious 
Seriousb Unlikely None Modera
te 
a Each patient in the event group was coupled with 2 “control” patients to compare 
effectiveness. Non-blinded. 
b Small sample size. 
c Italian based study 
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Table II: Outcome variables from the 
Antonelli et al Study4 
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Table III. Outcome variables from the 
Chidini et al Study5 
 
 
Figure 1:   Example of Helmet CPAP delivery system6 
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Figure 2: Example of Mask CPAP delivery system7 
 
 
 
 
 
  
 - 21 - Revised 07Dec2009 
 
APPENDIX 
Objective Pain Scale
 
